Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
Titel:
Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
Auteur:
Billon, Emilien Dalban, Cécile Oudard, Stephane Chevreau, Christine Laguerre, Brigitte Barthélémy, Philippe Borchiellini, Delphine Geoffrois, Lionnel Negrier, Sylvie Joly, Florence Thiery-Vuillemin, Antoine Gross-Goupil, Marine Rolland, Frederic Priou, Frank Mahammedi, Hakim Tantot, Florence Escudier, Bernard Chabaud, Sylvie Albiges, Laurence Gravis, Gwenaelle